Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures.
Eastern equine encephalomyelitis vaccines were prepared with virus propagated in stationary monolayer cultures and in concentrated suspension cultures of primary chick embryo cells. Virus pools for vaccine preparation were inactivated by three different methods: 0.05% formalin, 41 C heat, and 0.16% beta-propiolactone. Heat-and beta-propiolactone-inactivated vaccines maintained high hemagglutinating titers in the fluid state for at least 10 months, whereas formalin-inactivated vaccines lost their hemagglutinating activity within a few hours after treatment. The hemagglutinin of beta-propiolactone-inactivated virus particles was more dense than the hemagglutinin of the parent virus particles, as determined by sucrose density gradient centrifugation. The increase in density may be due to the degradation or removal of the lipid from the virus envelope. When administered to guinea pigs, all three vaccines stimulated hemagglutination-inhibiting, complement-fixing, and neutralizing antibodies and afforded protection against a live virus challenge. Test results showed that vaccines prepared with virus propagated in concentrated suspension cultures were more immunogenic and stimulated greater serologic responses in guinea pigs than vaccines derived from monolayer-propagated virus. The beta-propiolactone-inactivated vaccine was most protective, the heat-inactivated (41 C) vaccine next, and the formalin-inactivated vaccine least potent.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001103:Arboviruses / Q000276:immunology*; D002499:Centrifugation, Density Gradient; D002642:Chick Embryo; D003168:Complement Fixation Tests; D003470:Culture Media; D046508:Culture Techniques; D004355:Drug Stability; D004683:Encephalomyelitis, Equine / Q000276:immunology* / Q000517:prevention & control; D005069:Evaluation Studies as Topic; D005557:Formaldehyde; D006168:Guinea Pigs; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006389:Hemagglutinins, Viral / Q000032:analysis; D006571:Heterocyclic Compounds; D006358:Hot Temperature; D007120:Immunochemistry; D007783:Lactones; D051379:Mice; D009500:Neutralization Tests; D011422:Propionates; D013395:Sucrose; D013997:Time Factors; D014765:Viral Vaccines; D014776:Virus Cultivation
D000906:Antibodies; D003470:Culture Media; D006389:Hemagglutinins, Viral; D006571:Heterocyclic Compounds; D007783:Lactones; D011422:Propionates; D014765:Viral Vaccines; D005557:Formaldehyde; D013395:Sucrose